<DOC>
	<DOCNO>NCT02766998</DOCNO>
	<brief_summary>This prospective , single center , safety feasibility trial evaluate use autologous umbilical vein shunt conduits neonatal cardiac surgery . Subjects identify Advanced Fetal Care Center ( AFCC ) follow diagnosis congenital heart disease ( CHD ) single ventricle physiology fetus via fetal echocardiogram . At time cesarean section vaginal delivery , umbilical cord harvest sterile fashion umbilical vein dissect free preserve first clinically indicated Stage I palliative procedure day 3 7 life . Subjects followed Stage II palliative procedure .</brief_summary>
	<brief_title>Preserved Umbilical Vein Use Autologous Shunt Conduits Neonatal Cardiac Surgery</brief_title>
	<detailed_description />
	<mesh_term>Heart Defects , Congenital</mesh_term>
	<criteria>All fetal diagnosis complex congenital heart disease diagnose fetal echocardiogram require cardiac repair BlalockTaussig Shunt Right Ventricle Pulmonary Artery conduit eligible . This include prenatal diagnosis single ventricle circulation physiology ( SVP ) . Subjects deliver via cesarean section vaginally Brigham Women 's Hospital consider . meconium delivery symptomatic Group B Streptococcus ( GBS ) positive mother mother chorioamnionitis Hepatitis B C positive mother HIV positive mother . If unable collect viable cord day delivery already enrol subject , subject remove study day birth .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>1 Day</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>